# Diatrizoate Meglumine and Diatrizoate Sodium

NDC: 31722-019
Generic name: Diatrizoate Meglumine and Diatrizoate Sodium
Labeler / Manufacturer: Camber Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION
Routes: ORAL, RECTAL
Marketing started: 20231117

FDA application: ANDA215049

## Active ingredients

- DIATRIZOATE MEGLUMINE: 660 mg/mL
- DIATRIZOATE SODIUM: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"31722-019"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=31722-019
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a216a7d5-3c28-482b-956a-93ae146e3763